<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-80115</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Primary diffuse large B-cell lymphoma of the rectum simulating a rectal adenocarcinoma</dc:title>
<dc:description xml:lang="en">Colorectal lymphoma is an extremely infrequent entity, representing less than 0.5% of all primary colorectal neoplasms. Colorectal localization accounts for 15&#150;20% of all gastrointestinal lymphomas, after the stomach and small intestine. Because the symptoms are non-specific, this disease is usually diagnosed in the advanced stages. Dawson's criteria are highly useful in the differential diagnosis between primary colorectal involvement and gastrointestinal tract involvement secondary to systemic lymphoma, which is important due to the distinct prognosis and treatment of these entities. We report the case of a B-cell non-Hodgkin's lymphoma that was difficult to diagnose and was treated with R-CHOP polychemotherapy. Outcome was poor (AU)</dc:description>
<dc:creator>Marín García, David</dc:creator>
<dc:creator>Utrilla Ayala, María del Carmen</dc:creator>
<dc:creator>Cárdenas Lafuente, Francisco</dc:creator>
<dc:creator>Galán Jurado, María Victoria</dc:creator>
<dc:creator>García Ordóñez, Miguel Ángel</dc:creator>
<dc:creator>Jiménez Martín, Juan José</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El linfoma colorrectal es una entidad extremadamente infrecuente, representando menos del 0,5% del total de las neoplasias colorrectales primarias. La localización colorrectal supone el 15&#150;20% del total de los linfomas gastrointestinales, tras el estómago y el intestino delgado. Debido a la inespecificidad de los síntomas, la enfermedad suele estar avanzada en el momento del diagnóstico. Primordial interés tienen los criterios de Dawson para diferenciar la afectación colorrectal primaria de la afectación del tracto gastrointestinal secundaria a un linfoma sistémico, dadas sus diferentes connotaciones pronósticas y terapéuticas. Presentamos el caso de un linfoma no hodgkiniano tipo B de localización rectal, de difícil diagnóstico, tratado con esquema poliquimioterapéutico con ciclofosfamida, adriamicina, vincristina, prednisona y rituximab, cuya evolución fue desfavorable (AU)</dc:description>
<dc:source>Gastroenterol Hepatol;33(2): 92-98, feb. 2010. ilus, tab</dc:source>
<dc:identifier>ibc-80115</dc:identifier>
<dc:title xml:lang="es">Linfoma de tipo B difuso de células grandes primario rectal que simula un adenocarcinoma de recto</dc:title>
<dc:subject>^d29271^s22016</dc:subject>
<dc:subject>^d28214</dc:subject>
<dc:subject>^d12424^s22057</dc:subject>
<dc:subject>^d23947^s22073</dc:subject>
<dc:subject>^d238^s22053</dc:subject>
<dc:subject>^d238^s22016</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29341</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24375</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d22921</dc:subject>
<dc:subject>^d12424^s22016</dc:subject>
<dc:subject>^d29271^s22057</dc:subject>
<dc:subject>^d9560</dc:subject>
<dc:type>article</dc:type>
<dc:date>201002</dc:date>
</metadata>
</record>
</ibecs-document>
